Since the GPC, GNB, and acid-fast organisms isolated in the cohort (from 2003 to 2012) were most commonly sensitive to ciprofloxacin, it could still remain the first choice of antibiotic in the management of scleral buckle infection until the microbiological validation. Here, GYPC is linked to infection.